🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was to evaluate the pharmacokinetics and safety of SHR6390 at do...
Status
Completed
Location
Phase I Clinical Research Center
Start Date
2019-06-13
Trial ID
NCT05354336
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
SHR6390 is a small molecular,oral potent, selective CDK4/6 inhibitor. The p...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2016-01
Trial ID
NCT02671513
Treatments Being Tested
SHR6390 is a small molecular, oral potent, selective CDK4/6 inhibitor. The ...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2016-03-03
Trial ID
NCT02684266
Treatments Being Tested
This is a single-center, single-arm phase Ib / II clinical trial, which was...
Status
Unknown
Location
Cancer Center of Sun-Yat Sen University (CCSYSU)
Start Date
2023-07-01
Trial ID
NCT05952128
Treatments Being Tested
The aim of the study is to assess the safety and tolerability of SHR6390 co...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-07-27
Trial ID
NCT03480256
Treatments Being Tested
This is a Phase Ib/II , Open-label , Investigator-initiated Trail of SHR-12...
Status
Unknown
Location
Multiple Locations
Start Date
2018-07-30
Trial ID
NCT03601598
This is a Phase Ib/II, open-label, multi-center umbrella study evaluating t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-10-18
Trial ID
NCT03805399
Treatments Being Tested